Primary |
Hypertension |
58.8% |
Atrial Fibrillation |
7.3% |
Blood Pressure |
4.0% |
Knee Operation |
3.6% |
Angina Pectoris |
3.3% |
Essential Hypertension |
2.9% |
Cardiac Failure |
2.6% |
Cerebral Infarction |
2.6% |
Cerebral Thrombosis |
2.6% |
Cardiac Disorder |
2.2% |
Blood Pressure Abnormal |
1.8% |
Angina Unstable |
1.1% |
Hypersensitivity |
1.1% |
Pain |
1.1% |
Raynaud's Phenomenon |
1.1% |
Secondary Hypertension |
1.1% |
Colon Neoplasm |
0.7% |
Depression |
0.7% |
Diabetes Mellitus |
0.7% |
Glaucoma |
0.7% |
|
Oedema Peripheral |
11.1% |
Palpitations |
8.3% |
Atrial Fibrillation |
6.9% |
Orthostatic Hypotension |
6.9% |
Drug Ineffective |
5.6% |
Hypertension |
5.6% |
Tooth Loss |
5.6% |
Wrong Drug Administered |
5.6% |
Blood Pressure Increased |
4.2% |
Fatigue |
4.2% |
Gingival Swelling |
4.2% |
Pharmaceutical Product Complaint |
4.2% |
Rash |
4.2% |
Vasculitic Rash |
4.2% |
Ventricular Extrasystoles |
4.2% |
Wrong Technique In Drug Usage Process |
4.2% |
Anaphylactic Reaction |
2.8% |
Anaphylactoid Reaction |
2.8% |
Atrioventricular Block Complete |
2.8% |
Cerebrovascular Accident |
2.8% |
|
Secondary |
Hypertension |
34.4% |
Atrial Fibrillation |
18.4% |
Cardiac Failure |
14.9% |
Product Used For Unknown Indication |
7.2% |
Drug Use For Unknown Indication |
4.8% |
Cerebral Thrombosis |
4.0% |
Cerebral Infarction |
2.9% |
Ill-defined Disorder |
2.7% |
Blood Pressure |
1.9% |
Raynaud's Phenomenon |
1.6% |
Cardiac Disorder |
1.1% |
Asthma |
0.8% |
Blood Pressure Abnormal |
0.8% |
Colon Neoplasm |
0.8% |
Gastrooesophageal Reflux Disease |
0.8% |
Pain |
0.8% |
Acute Coronary Syndrome |
0.5% |
Cardiovascular Event Prophylaxis |
0.5% |
Systolic Hypertension |
0.5% |
Vascular Graft |
0.5% |
|
Oedema Peripheral |
23.3% |
Weight Decreased |
11.0% |
Syncope |
8.2% |
Hypertension |
6.8% |
Ventricular Extrasystoles |
5.5% |
Bladder Tamponade |
4.1% |
Jaundice |
4.1% |
Vomiting |
4.1% |
Atrial Fibrillation |
2.7% |
Cerebrovascular Accident |
2.7% |
Drug Ineffective |
2.7% |
Headache |
2.7% |
Hypotension |
2.7% |
Recurrent Cancer |
2.7% |
Sensation Of Heaviness |
2.7% |
Temperature Intolerance |
2.7% |
Thrombosis |
2.7% |
Urticaria |
2.7% |
Vasculitic Rash |
2.7% |
Weight Increased |
2.7% |
|
Concomitant |
Drug Use For Unknown Indication |
20.8% |
Hypertension |
19.1% |
Product Used For Unknown Indication |
16.5% |
Nuclear Magnetic Resonance Imaging |
6.7% |
Pain |
5.1% |
Diabetes Mellitus |
3.5% |
Rheumatoid Arthritis |
3.3% |
Depression |
2.7% |
Osteoporosis |
2.3% |
Angiogram |
2.2% |
Anxiety |
2.2% |
Hormone Replacement Therapy |
2.0% |
Arthritis |
2.0% |
Nuclear Magnetic Resonance Imaging Brain |
1.8% |
Atrial Fibrillation |
1.7% |
Blood Pressure |
1.7% |
Cardiac Disorder |
1.7% |
Fistulogram |
1.7% |
Chemotherapy |
1.6% |
Type 2 Diabetes Mellitus |
1.6% |
|
Vomiting |
9.8% |
Weight Decreased |
9.5% |
Weight Increased |
8.6% |
Myocardial Infarction |
6.8% |
Renal Failure |
5.6% |
Vision Blurred |
5.6% |
Urinary Tract Infection |
5.3% |
Transient Ischaemic Attack |
4.7% |
Cerebrovascular Accident |
4.4% |
Pneumonia |
4.4% |
Type 2 Diabetes Mellitus |
4.4% |
Oedema Peripheral |
4.1% |
Pyrexia |
4.1% |
Somnolence |
3.8% |
Drug Ineffective |
3.3% |
Renal Failure Acute |
3.3% |
Wound Infection Staphylococcal |
3.3% |
Malaise |
3.0% |
Rash |
3.0% |
Skin Tightness |
3.0% |
|
Interacting |
Chronic Hepatitis C |
66.7% |
Hypertension |
33.3% |
|
Palpitations |
33.3% |
Spinal Compression Fracture |
33.3% |
Syncope |
33.3% |
|